טוען...
Clinical correlates of response to anti-PD-1-based therapy in patients with metastatic melanoma
Anti-PD-1 agents, alone or in combination with ipilimumab, produce durable responses in some melanoma patients. Tumor features that correlate with response are not well defined. We collected clinical data from metastatic melanoma patients treated at two centers who received anti-PD-1 (n=303) or anti...
שמור ב:
| הוצא לאור ב: | J Immunother |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6561788/ https://ncbi.nlm.nih.gov/pubmed/30882548 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0000000000000258 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|